EPISODE · Jul 21, 2026 · 2 MIN
FDA's $30B Peptides Decision: Telehealth's Next Big Shift | OWITH Daily
from OWITH.ai - Only What's Important to Hear around AI and Tech · host owith.ai
Good morning from OWITH.ai: the podcast that gives you only what's important to hear in the AI and tech world. A significant development is on the horizon with the FDA's upcoming decision regarding the approval of seven wellness peptides for legal compounding by specialty pharmacies. These peptides, known for their potential benefits like boosting energy and slowing aging, could initiate a substantial market shift, potentially creating telehealth's next multibillion-dollar opportunity. Companies such as Hims & Hers are closely monitoring this development, anticipating that FDA approval could open new avenues for telehealth platforms. With a potential market value estimated at around $30 billion, the landscape could see a surge in new platforms offering peptide programs, marking a competitive phase in this emerging field. Shifting our focus to artificial intelligence, there's an intriguing discussion surrounding Chinese AI models, particularly the Kimi K3, and their implications on the global tech industry. The discourse explores how AI is influencing cost structures and centralized business models. A key takeaway is that while Chinese models seem economically competitive due to supply constraints faced by Western firms, concerns about cybersecurity and strategic competitiveness remain valid. The narrative emphasizes the importance of adopting open-source principles within U.S. policy to foster innovation and maintain a competitive edge without over-relying on foreign models. In another fascinating development, prediction markets reached a notable milestone in July 2026 with Kalshi and Polymarket recording $5.7 billion in bets on FIFA's World Cup final. This surge in betting underscores the growing influence of predictive market companies and their appeal to Silicon Valley investors. In parallel, delivery apps like DoorDash are reshaping the food delivery landscape by challenging major pizza chains, prompting strategic shifts within these companies. Additionally, Apple is testing an AI-based "Live Notes" system at its retail locations to enhance customer engagement—a move that could revolutionize retail interactions. Now let's explore an emerging concept known as "agentic commerce," where AI agents autonomously conduct buying and selling transactions. This development necessitates robust infrastructure to ensure transactions are efficient and compliant. Blockchain technology plays a pivotal role here, acting as the underlying operating system for this new economy. Notable entries like USDC stablecoin are gaining regulatory traction, signaling a shift towards integrating stablecoins in financial systems. Companies are poised to redefine competitive dynamics by leveraging agentic commerce to expand market opportunities, highlighting how technological advancements continue to reshape economic landscapes. Thank you for tuning in to today's episode of OWITH.ai—your go-to podcast for crucial updates in AI and technology. Stay tuned for more insights and developments in our future episodes!Support the showThanks for listening! Follow us on Twitter, Instagram and Linkedin
Embed this episode
What this episode covers
Good morning from OWITH.ai: the podcast that gives you only what's important to hear in the AI and tech world. A significant development is on the horizon with the FDA's upcoming decision regarding the approval of seven wellness peptides for legal compounding by specialty pharmacies. These peptides, known for their potential benefits like boosting energy and slowing aging, could initiate a substantial market shift, potentially creating telehealth's next multibillion-dollar opportunity. Compa...
NOW PLAYING
FDA's $30B Peptides Decision: Telehealth's Next Big Shift | OWITH Daily
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.